Grapevine: Dr Reddy’s, Torrent eye M&As; True North racks up $78 mn for credit fund

Premium

Drugmaker Dr Reddy’s Laboratories has joined the fray with biopharmaceutical company Samsung Bioepis to take over US-based Biogen’s biosimilar business, a media report said.    The deal is likely to be pegged at $1 billion, The Economic Times report, citing two people close to the matter.   Last week, Mint reported that Ahmedabad-based Intas Pharmaceuticals Ltd was preparing a bid for Biogen’s biosimilar business in a transaction that ......